| abstract |
The subject matter disclosed herein is for multispecific antibodies, such as bispecific and biepitopic antibodies, as well as methods for screening such antibodies, and screening for such bispecific and biepitopic antibodies. It relates to novel antibody structures that can be used. The present disclosure further provides bispecific anti-KLB antibodies and methods of treating diseases using these antibodies. [Selection figure] None |